Search results
Results from the Health.Zone Content Network
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees.
The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and is represented in 13 countries in Europe. In the 2019 financial year the company achieved a turnover of EUR 21.18 billion. The majority shareholder of the company is the US-based McKesson Corporation, which holds a share of 77.01%.
John Hammergren. (1959-02-20) 20 February 1959 (age 65) Saint Paul, Minnesota, U.S. Occupation (s) CEO of McKesson Corporation, Retired. John H. Hammergren is an American businessman. He is best known for his role as chairman and CEO of McKesson Corporation since 1999. [1] On November 1, 2018, Hammergren announced his plan to retire. [2]
McKesson Releases FY2012 Corporate Citizenship Report Report showcases community engagement, employee health & safety, philanthropy, sustainability, supplier diversity and other programs SAN ...
Operating profit was $1.3 billion, an increase of 12%, driven by $110 million of pre-tax gains associated with McKesson Ventures' equity investments included in corporate expenses compared to pre ...
The McKesson and Robbins scandal was a major financial scandal in 1938, involving McKesson and Robbins, Inc, now McKesson Corporation. It is widely considered one the largest financial scandals of the 20th century. McKesson and Robbins was taken over in 1925 by Phillip Musica, who previously used Adelphia Pharmaceutical Manufacturing Company as ...
The company did report only flat revenue for its Technology Solutions business due partially to "revenue deferral for [its] international business." However, the segment only accounts for 3% of ...
McKesson Canada purchased Rexall in December 2016 for $3 billion from the Katz Group of Companies. [5] At the time, it was estimated that Rexall had an average annual revenue of approximately $2.0 to $2.5 billion. [6] Around this period, one of the major rival pharmacies in Canada was Shoppers Drug Mart. [7]